• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项将美沙酮维持治疗纳入适应性治疗模式的为期12个月的对照试验。

A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.

作者信息

King Van L, Kidorf Michael S, Stoller Kenneth B, Schwartz Robert, Kolodner Kenneth, Brooner Robert K

机构信息

The Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center, Baltimore, MD 21224, USA.

出版信息

J Subst Abuse Treat. 2006 Dec;31(4):385-93. doi: 10.1016/j.jsat.2006.05.014. Epub 2006 Aug 14.

DOI:10.1016/j.jsat.2006.05.014
PMID:17084792
Abstract

Methadone medical maintenance (MMM) reduces the reporting schedule for stable and well-functioning methadone maintenance patients to once a month, with counseling provided by medical staff. We report on the 12-month outcomes of 92 highly stable methadone maintenance patients randomly assigned to one of three study conditions: routine care, MMM at the methadone maintenance program, and MMM at a physician's office. Methadone medical maintenance patients received a 28-day supply of methadone, whereas routine care patients received five or six take-home methadone doses each week. All patients performed a medication recall once a month and submitted two urine samples each month. An adaptive stepped-care system of treatment intensification was used for patients who failed recall or who had drug-positive urine specimens. Seventy-seven patients completed the 12-month study period. Dropout was caused primarily by problems with handling methadone and disliking the recall frequency. There were low rates of drug use or failed medication recall. Treatment satisfaction was high in all groups, but the MMM patients initiated more new employment or family/social activities than did routine care patients over the study period. The stepped-care approach was well tolerated and matched patients to an appropriate step of service within a continuum of treatment intensity.

摘要

美沙酮维持治疗(MMM)将病情稳定、功能良好的美沙酮维持治疗患者的报告频率减至每月一次,并由医务人员提供咨询服务。我们报告了92名高度稳定的美沙酮维持治疗患者的12个月治疗结果,这些患者被随机分配至三种研究条件之一:常规护理、在美沙酮维持治疗项目中接受MMM,以及在医生办公室接受MMM。接受MMM的患者获得了为期28天的美沙酮供应,而接受常规护理的患者每周领取五或六次美沙酮带回家服用剂量。所有患者每月进行一次用药回忆,并每月提交两份尿液样本。对于回忆失败或尿液样本药物检测呈阳性的患者,采用了适应性逐步强化治疗系统。77名患者完成了12个月的研究期。退出主要是由于美沙酮处理问题和不喜欢回忆频率。药物使用或用药回忆失败的发生率较低。所有组的治疗满意度都很高,但在研究期间,接受MMM的患者比接受常规护理的患者开始了更多新的工作或家庭/社交活动。逐步强化治疗方法耐受性良好,能使患者在连续的治疗强度范围内匹配到适当的服务级别。

相似文献

1
A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.一项将美沙酮维持治疗纳入适应性治疗模式的为期12个月的对照试验。
J Subst Abuse Treat. 2006 Dec;31(4):385-93. doi: 10.1016/j.jsat.2006.05.014. Epub 2006 Aug 14.
2
Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.在社区诊所实施美沙酮维持治疗:推广循证治疗
J Subst Abuse Treat. 2008 Oct;35(3):312-21. doi: 10.1016/j.jsat.2007.12.002. Epub 2008 Feb 21.
3
A multicenter randomized evaluation of methadone medical maintenance.
Drug Alcohol Depend. 2002 Jan 1;65(2):137-48. doi: 10.1016/s0376-8716(01)00155-7.
4
A randomized controlled trial of interim methadone maintenance.美沙酮维持治疗中期的一项随机对照试验。
Arch Gen Psychiatry. 2006 Jan;63(1):102-9. doi: 10.1001/archpsyc.63.1.102.
5
Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice--a summary report (1983-1998).美沙酮药物维持治疗(MMM):私人医疗实践中治疗慢性阿片类药物依赖——总结报告(1983 - 1998)
Mt Sinai J Med. 2000 Oct-Nov;67(5-6):388-97.
6
Controlled trial of prescribed heroin in the treatment of opioid addiction.处方海洛因治疗阿片类药物成瘾的对照试验。
J Subst Abuse Treat. 2006 Sep;31(2):203-11. doi: 10.1016/j.jsat.2006.04.007. Epub 2006 Jul 18.
7
Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.丁丙诺啡维持治疗和美沙酮维持治疗的海洛因成瘾患者12个月内的物质使用情况及生活质量
J Subst Abuse Treat. 2007 Jul;33(1):91-8. doi: 10.1016/j.jsat.2006.11.009. Epub 2007 Jan 16.
8
The prevalence of mental and physical health disorders among older methadone patients.老年美沙酮患者中精神和身体健康障碍的患病率。
Am J Geriatr Psychiatry. 2008 Jun;16(6):488-97. doi: 10.1097/JGP.0b013e31816ff35a.
9
Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.与海洛因使用者相比,处方类阿片类药物主要使用者在美沙酮维持药物治疗中的留存情况。
Addiction. 2009 May;104(5):775-83. doi: 10.1111/j.1360-0443.2009.02538.x. Epub 2009 Mar 13.
10
Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.美沙酮维持治疗中阿片类成瘾者的问题饮酒与治疗结果的关系
Drug Alcohol Rev. 2007 Jan;26(1):55-63. doi: 10.1080/09595230601036994.

引用本文的文献

1
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis.新冠疫情放松美沙酮居家服药规定后,两家农村阿片类药物治疗项目中的治疗保留率、重返使用率和康复支持:混合方法分析。
J Subst Abuse Treat. 2022 Oct;141:108801. doi: 10.1016/j.jsat.2022.108801. Epub 2022 May 8.
2
The Methadone Manifesto: Treatment Experiences and Policy Recommendations From Methadone Patient Activists.《美沙酮宣言:美沙酮患者维权人士的治疗经历与政策建议》
Am J Public Health. 2022 Apr;112(S2):S117-S122. doi: 10.2105/AJPH.2021.306665.
3
Treatment provider perceptions of take-home methadone regulation before and during COVID-19.
治疗提供者对 COVID-19 前后美沙酮可携法规的看法。
Drug Alcohol Depend. 2021 Nov 1;228:109100. doi: 10.1016/j.drugalcdep.2021.109100. Epub 2021 Sep 23.
4
Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review.基于办公室的美沙酮治疗阿片类药物使用障碍和药房配药:范围综述。
Am J Psychiatry. 2021 Sep 1;178(9):804-817. doi: 10.1176/appi.ajp.2021.20101548. Epub 2021 Jul 28.
5
Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.新冠疫情期间康涅狄格州美沙酮项目实践的变化及美沙酮过量致死率
J Subst Abuse Treat. 2021 Dec;131:108449. doi: 10.1016/j.jsat.2021.108449. Epub 2021 Apr 29.
6
A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder.呼吁在阿片类药物成瘾临床试验中定义疗效的共识:接受药物辅助治疗阿片类药物使用障碍的患者进行系统评价和定性研究的综合结果。
Trials. 2020 Jan 6;21(1):30. doi: 10.1186/s13063-019-3995-y.
7
Matching Treatment to Rhetoric - A Challenge to Policy and Programming.使治疗与言辞相匹配——对政策与规划的一项挑战
J Subst Abuse Treat. 2016 May;64:1-2. doi: 10.1016/j.jsat.2015.06.025. Epub 2015 Dec 8.
8
Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis.慢性疼痛对阿片类物质使用障碍患者治疗预后的影响:一项系统评价和荟萃分析。
Subst Abuse. 2015 Sep 10;9:59-80. doi: 10.4137/SART.S30120. eCollection 2015.
9
Ukrainian prisoners and community reentry challenges: implications for transitional care.乌克兰囚犯与社区重新融入的挑战:对过渡性护理的影响
Int J Prison Health. 2013;9(1):5-19. doi: 10.1108/17449201311310760.
10
A critical analysis of user satisfaction surveys in addiction services: opioid maintenance treatment as a representative case study.成瘾服务中用户满意度调查的批判性分析:以阿片类药物维持治疗为例的代表性案例研究
Patient Prefer Adherence. 2014 Jan 21;8:107-17. doi: 10.2147/PPA.S52060. eCollection 2014.